Episode 3: Article Reviews: Progress and Challenges in Anti-Obesity Pharmacotherapy

August 05, 2019 00:10:52
Episode 3: Article Reviews: Progress and Challenges in Anti-Obesity Pharmacotherapy
Obesity: A Disease
Episode 3: Article Reviews: Progress and Challenges in Anti-Obesity Pharmacotherapy

Aug 05 2019 | 00:10:52

/

Show Notes

Episode Description In our article review podcasts, we have carefully selected recent articles included in the latest version of the OMA Obesity Algorithm.  We then discuss this new science with obesity experts. In this episode, Harold Bays, MD, FOMA, FTOS, FACC, FACE, FNLA, Dipl. ABOM interviews Larry Richardson, MD, MFOMA about a recent publication on progress and challenges in anti-obesity pharmacotherapy. Topics covered include: barriers to the use of anti-obesity medication, new, most promising agents being considered that may come to fruition, and dialoging about the resistance of combination therapy for treating obesity. To access other resources from the clinical leader in Obesity Medicine, visit: www.obesitymedicine.org. Episode Guests Article Reviewed

Other Episodes

Episode

July 29, 2024 00:21:41
Episode Cover

Episode 97: Clinical Conversations: Combining Medical-Surgical Obesity Care

In this Episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings interviews, Dr. Kirsten Frederiksen, a highlighted speaker from the Obesity...

Listen

Episode 0

August 03, 2020 00:14:18
Episode Cover

Episode 22: Article Reviews: The role ultra-processed diets play in weight gain

Episode Description In this episode, the OMA Chief Science Officer, Harold Bays, MD, FOMA Dipl. ABOM interviews Justin Tondt, MD, reviewing a recent article...

Listen

Episode 0

April 26, 2023 00:15:13
Episode Cover

Episode 81: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 2 of 3

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts...

Listen